Processa Pharmaceuticals (PCSA) EPS (Diluted) (2016 - 2026)
Powered by 
Analysis
Processa Pharmaceuticals (PCSA) EPS (Diluted) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 1.67 |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -0.04 |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 0.33 |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | -3.06 |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 2.81 |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 7.27 |
| 10 | Processa Pharmaceuticals | 5.75 Mn | 5.75 Mn | - | -1.19 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.19 |
| Mar 31, 2026 | -1.29 |
| Dec 31, 2025 | -2.57 |
| Sep 30, 2025 | -3.46 |
| Jun 30, 2025 | -6.32 |
| Mar 31, 2025 | -7.44 |
| Dec 31, 2024 | -22.29 |
| Sep 30, 2024 | -25.83 |
| Jun 30, 2024 | -25.23 |
| Mar 31, 2024 | -27.63 |
| Dec 31, 2023 | -45.84 |
| Sep 30, 2023 | -38.55 |
| Jun 30, 2023 | -48.50 |
| Mar 31, 2023 | -88.31 |
| Dec 31, 2022 | -403.87 |
| Sep 30, 2022 | -185.82 |
| Jun 30, 2022 | -161.99 |
| Mar 31, 2022 | -346.52 |
| Dec 31, 2021 | -341.87 |
| Sep 30, 2021 | -320.76 |